Skip to content

BillionToOne, Inc. BLLN Change in Deferred Revenue

Change in Deferred Revenue at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
-$32.1M-261%
Guardant Health logo
Guardant HealthGH
-$3.23M-233%
Natera, Inc. logo
Natera, Inc.NTRA
$11.88M+1,671%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$0+100%
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
-$428K-18.6%

Other financials

Income statement

See full
Revenue$108.4M+83.8%
Gross profit$79.1M+108%
Operating income$17.8M+870%
Net income$18.0M+551%
EPS (diluted)$0.34+187%

Balance sheet

See full
Cash & equivalents$537.5M+181%
Total debt$144.2M
Total equity$505.6M+300%
Total assets$700.7M

Cash flow

See full
Operating cash flow$15.4M+488%
CapEx$4.5M+90.5%
Free cash flow$11.0M+3,842%

Valuation

See full
Market cap$4.84B

Profitability

See full
Gross margin70.4%
Operating margin-96.9%
Net margin8.4%
FCF margin-83.4%

Returns & leverage

See full
Debt / equity0.3×
Current ratio10.9×

Where this comes from

Reported directly by BillionToOne, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInContractWithCustomerLiability.

The official record: BillionToOne, Inc. ’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about BillionToOne, Inc. 's change in deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BillionToOne, Inc. 's change in deferred revenue?
BillionToOne, Inc. (BLLN) reported change in deferred revenue of -$682K in Q1 2026.
How has BillionToOne, Inc. 's change in deferred revenue changed year-over-year?
BillionToOne, Inc. 's change in deferred revenue decreased by 236.0% year-over-year, from -$203K to -$682K.
What does change in deferred revenue mean?
Change in payments received from customers for goods/services not yet delivered — a key SaaS and subscription metric.